Potential drug-herb interaction with antiplatelet/anticoagulant drugs

Complementary Therapies in Clinical Practice

Volumn 12, Issue 4, 2006, Pages 236-241

  Saw, Jun Tze ^a   Bahari, Mohd Baidi ^a   Ang, Hooi Hoon ^a   Lim, Yu Hoe ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Anticoagulant; Antiplatelet; Disclosure; Drug herb interactions

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FEMALE; GARLIC; GINKGO BILOBA; GINSENG; HERB DRUG INTERACTION; HUMAN; MALAYSIA; MALE; MEDICINAL PLANT; MIDDLE AGED; PHYTOTHERAPY; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; FEMALE; GARLIC; GINKGO BILOBA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERB-DRUG INTERACTIONS; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PANAX; PHYTOTHERAPY; PLANTS, MEDICINAL; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES;

EID: 33749342660     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2006.06.002     Document Type: Article

References (33)

1. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
2. Bensoussan A, Myers SP. Towards a safer choice. The practice of traditional Chinese medicine in Australia. Sydney. URL: http://www.dhs.vic.gov.au/pdpd/chinese/report/contents.html (accessed June 2005).
3. Kuo G.M., Hawley S.T., Weiss L.T., et al. Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complementary Alternative Medicine 4 (2004) 18
4. Brazier N.C., and Levine M.A.H. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 10 (2003) 163-169
5. Barnes J., Mills S.Y., Abbot N.C., et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of medical remedies. Br J Clin Pharmacol 45 (1998) 496-500
6. Fugh-Berman A. Herb-drug interaction. Lancet 355 (2000) 134-138
7. Izzo A., and Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 61 15 (2001) 2163-2175
8. Hirsh J., and Fuster V. Guide to anticoagulant therapy part 2: oral anticoagulants. Circulation 89 (1994) 1469-1480
9. Fugh-Berman A., and Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 52 (2001) 587-595
10. Rhee S.M., Garg V.K., and Hershey C.O. Use of complementary and alternative medicines by ambulatory patients. Arch Intern Med 164 (2004) 1004-1009
11. Kelly J.P., Kaufman D.W., Kelly K., et al. Recent trends in use of herbal and other natural products. Arch Intern Med 165 (2005) 281-286
12. Druss B.G., and Rosenheck R.A. Association between use of unconventional therapies and conventional medical services. JAMA 282 (1998) 651-656
13. Smith L., Ernst E., Ewings P., et al. Co-ingestion of herbal products with warfarin. Br J Gen Pract 54 (2004) 439-441
14. Sunter W.H. Warfarin and garlic. Pharm J 246 (1991) 772
15. Janetzky K., and Morreale A.P. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 54 (1997) 692-693
16. Zhu M., Chan K.W., Ng L.S., et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 51 (1999) 175-180
17. Jiang X., Williams K.M., Liauw W.S., et al. Effects of St. John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 57 5 (2004) 592-599
18. Ernst E. Complementary therapies for asthma: what patients use. J Asthma 35 (1998) 667-671
19. Myers S.P., and Cheras P.A. The other side of the coin: safety of complementary and alternative medicine. MJA 181 (2004) 222-225
20. De Smet P. Herbal Remedies. N Engl J Med 347 25 (2002) 2046-2056
21. BPFK. National Pharmaceutical Control Bureau, Malaysia. URL: http://www.bpfk.gov.my (accessed June 2005).
22. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the united states-prevalence, costs, and patterns of use. N Engl J Med 328 4 (1993) 246-252
23. Eisenberg D.M., Kessler R.C., Van Rompay M.I., et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 135 (2001) 344-351
24. MacLennan A.H., Wilson D.H., and Taylor A.W. The escalating cost and prevalence of alternative medicine. Prevent Med 35 (2002) 166-173
25. National Center for Complementary and Alternative Medicine (NCCAM): get the facts: herbal supplements: consider safety, too. URL: http://www.nccm.nih.gov/health (accessed June 2005).
26. Scott C.J., and Riedlinger J. Promoting education about complementary or alternative medical therapies. Am J Health-Syst Pharm 55 (1998) 2525-2527
27. Heck A.M., Dewitt B.A., and Lukes A.L. Potential interactions between alternative therapies and warfarin. Am J Health-Syst Pharm 57 (2000) 1221-1230
28. Capasso F., et al. Phytotherapy: a quick reference to herbal medicines (2003), Springer, Berlin, Heidelberg
29. Izzo A. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 19 (2004) 1-16
30. Semaan N. Part III herbal medicine-drug interactions: the role of the pharmacist. Curr Probl Cancer, July/August 2000.
31. Page R.L., and Lawrence J.D. Potentiation of warfarin by dong quai. Pharmacotherapy (1999) 870-876
32. Miller L.G. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158 (1998) 2200-2211
33. Pheatt N. Nonherbal dietary supplements. Pharmacist's letter continuing education booklet 98 (1998) l-50